Buspirone to improve compliance in venlafaxine-induced movement disorder.
Pavlovic
Zoran M
ZM
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D002065:Buspirone / Q000627:therapeutic use*; D003187:Compliance; D003511:Cyclohexanols / Q000009:adverse effects*; D003865:Major Depressive Disorder / Q000188:drug therapy / Q000523:psychology; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D017366:Serotonin Receptor Agonists; D000069470:Venlafaxine Hydrochloride; D002065:Buspirone